Hartford Financial Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181K Hold
6,429
0.05% 130
2025
Q4
$160K Hold
6,429
0.04% 133
2025
Q3
$164K Sell
6,429
-100
-2% -$2.47K 0.04% 136
2025
Q2
$158K Hold
6,529
0.04% 136
2025
Q1
$165K Hold
6,529
0.03% 156
2024
Q4
$173K Buy
6,529
+529
+9% +$14.3K 0.04% 158
2024
Q3
$174K Hold
6,000
0.04% 158
2024
Q2
$168K Buy
6,000
+875
+17% +$24.1K 0.04% 161
2024
Q1
$142K Buy
5,125
+2,000
+64% +$55.5K 0.03% 163
2023
Q4
$90K Sell
3,125
-1,652
-35% -$49.9K 0.02% 189
2023
Q3
$158K Hold
4,777
0.04% 164
2023
Q2
$175K Buy
4,777
+2,165
+83% +$84.3K 0.04% 162
2023
Q1
$107K Sell
2,612
-48,177
-95% -$2.08M 0.03% 177
2022
Q4
$2.6M Sell
50,789
-500
-1% -$24K 0.69% 53
2022
Q3
$2.24M Buy
51,289
+95
+0.2% +$4.62K 0.66% 57
2022
Q2
$2.68M Hold
51,194
0.74% 48
2022
Q1
$2.65M Hold
51,194
0.64% 59
2021
Q4
$3.02M Sell
51,194
-286
-0.6% -$14.2K 0.7% 58
2021
Q3
$2.21M Buy
51,480
+146
+0.3% +$6.47K 0.56% 65
2021
Q2
$2.01M Hold
51,334
0.5% 75
2021
Q1
$1.86M Buy
51,334
+157
+0.3% +$5.57K 0.46% 77
2020
Q4
$1.88M Sell
51,177
-2,764
-5% -$101K 0.5% 72
2020
Q3
$1.88M Hold
53,941
0.56% 66
2020
Q2
$1.67M Sell
53,941
-105
-0.2% -$3.57K 0.53% 68
2020
Q1
$1.67M Sell
54,046
-422
-0.8% -$14.4K 0.67% 49
2019
Q4
$2.02M Sell
54,468
-1,159
-2% -$41.3K 0.63% 57
2019
Q3
$1.9M Buy
55,627
+949
+2% +$34.5K 0.63% 57
2019
Q2
$2.25M Hold
54,678
0.75% 43
2019
Q1
$2.2M Sell
54,678
-422
-0.8% -$16.9K 0.75% 46
2018
Q4
$2.28M Sell
55,100
-2,108
-4% -$87.5K 0.87% 37
2018
Q3
$2.39M Sell
57,208
-2,108
-4% -$81.2K 0.81% 39
2018
Q2
$2.04M Buy
59,316
+50,396
+565% +$1.72M 0.73% 45
2018
Q1
$300K Buy
8,920
+527
+6% +$18.1K 0.15% 102
2017
Q4
$288K Buy
8,393
+211
+3% +$7.2K 0.14% 108
2017
Q3
$277K Sell
8,182
-817
-9% -$26.3K 0.14% 109
2017
Q2
$286K Buy
8,999
+880
+11% +$27.8K 0.13% 111
2017
Q1
$263K Hold
8,119
0.16% 102
2016
Q4
$250K Buy
8,119
+316
+4% +$9.65K 0.15% 105
2016
Q3
$250K Buy
7,803
+192
+3% +$6.42K 0.15% 104
2016
Q2
$254K Buy
7,611
+105
+1% +$3.35K 0.15% 98
2016
Q1
$211K Buy
7,506
+181
+2% +$5.17K 0.13% 108
2015
Q4
$224K Buy
7,325
+2,108
+40% +$66.3K 0.14% 100
2015
Q3
$155K Hold
5,217
0.1% 113
2015
Q2
$165K Buy
+5,217
New +$170K 0.1% 118
2015
Q1
Sell
-5,217
Closed -$154K 195
2014
Q4
$154K Hold
5,217
0.09% 114
2014
Q3
$146K Sell
5,217
-229
-4% -$6.43K 0.09% 122
2014
Q2
$153K Sell
5,446
-42
-0.8% -$1.2K 0.09% 115
2014
Q1
$167K Hold
5,488
0.11% 111
2013
Q4
$159K Hold
5,488
0.1% 113
2013
Q3
$149K Hold
5,488
0.1% 114
2013
Q2
$146K Buy
+5,488
New +$152K 0.1% 115

Other funds holding PFE

Hartford Financial Management's PFE Position: Q1 2026 in Review

Hartford Financial Management held its Pfizer (PFE) position steady in Q1 2026 at 6,429 shares worth $181K. The position accounts for 0.05% of the portfolio, ranked #130.

Hartford Financial Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.02M in Q4 2021. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hartford Financial Management held 6,429 shares of Pfizer worth $181K as of Q1 2026.
  • Hartford Financial Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.05% of Hartford Financial Management's portfolio in Q1 2026, its #130 holding.
  • Hartford Financial Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Hartford Financial Management's Pfizer position peaked at $3.02M in Q4 2021.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.